 |
|
|
| |
Once-Daily Dolutegravir(DTG; S/GSK1349572) is Non-Inferior to Raltegravir (RAL) in Antiretroviral-naïve Adults. 48 Week results from SPRING-2 (ING113086)
|
| |
| |
Reported by Jules Levin 19th Intl AIDS Conf Wash DC July 22-27 2012
Presented by Francois Raffi for the investigator team.
|
| |
|
|
|
|
|
